Active, Not Recruiting
Study to Determine if the Flu Vaccine Increases the Risk of Muscle Damage in Participants Taking Drugs That Block Certain Proteins Made by Some Types of Immune System Cells - CA209-99J
Updated: 22 August, 2018 | ClinicalTrials.gov
Print Friendly Summary
Trial Details
Gender(s)
Age Range
Active, Not Recruiting
Treatment Options
Inclusion Criteria: - Treatment with a checkpoint inhibitor (CPI) - Age greater than or equal to 18 years on date of first claim for a CPI - ICD-9 or ICD-10 code for a malignancy within 180 days prior to the first claim for any CPI, and - Greater than or equal to 180 days of continuous pharmaceutical and medical benefit enrollment in the database prior to the first claim for any CPI Exclusion Criteria: - Less than 18 years of age Other protocol defined inclusion/exclusion criteria could apply
We strongly recommend you contact BMS to report Side Effects (Adverse Events)
Side Effects (Adverse Events) and other reportable events are defined here
Report Side Effects (Adverse Events) or Product Quality Complaints: Medical Information
